Related Experiment Video
Updated: Jul 14, 2025

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation
Published on: August 13, 2013
TRIM11 attenuates Treg cell differentiation by p62-selective autophagic degradation of AIM2
Ting Yu1, Xiaofang Yang2, Qiang Fu3
1The Second Affiliated Hospital, The State Key Laboratory of Respiratory Disease, Guangdong Provincial Key Laboratory of Allergy & Clinical Immunology, Guangzhou Medical University, Guangzhou, China; Department of Pharmacy, Hainan General Hospital/Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.
Abstract:
Ubiquitination is an important protein modification that regulates diverse biological processes, including CD4+ T cell differentiation and functions. However, the function of most E3 ubiquitin ligases in CD4+ T cell differentiation and CD4+ T cell-mediated pathological diseases remains unclear. In this study, we find that tripartite motif-containing motif 11 (TRIM11) specifically negatively regulates regulatory T (Treg) cell differentiation in CD4+ T cells and promotes autoimmune disease development in an AIM2-dependent manner. Mechanistically, TRIM11 interacts with absent in melanoma 2 (AIM2) and promotes the selective autophagic degradation of AIM2 by inducing AIM2 ubiquitination and binding to p62 in CD4+ T cells. AIM2 attenuates AKT and FOXO1 phosphorylation, MYC signaling, and glycolysis, thereby promoting the stability of Treg cells during experimental autoimmune encephalomyelitis (EAE). Our findings suggest that TRIM11 serves as a potential target for immunotherapeutic intervention for dysregulated immune responses that lead to autoimmunity and cancers.
Insights
Tripartite motif-containing motif 11 (TRIM11) negatively regulates regulatory T (Treg) cell differentiation and promotes autoimmune disease by degrading absent in melanoma 2 (AIM2). Targeting TRIM11 may offer new treatments for autoimmune disorders.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Ubiquitination is a key protein modification regulating CD4+ T cell differentiation and function.
- The roles of most E3 ubiquitin ligases in CD4+ T cell differentiation and related pathologies are not fully understood.
Purpose of the Study:
- To investigate the function of tripartite motif-containing motif 11 (TRIM11) in CD4+ T cell differentiation and autoimmune disease.
- To elucidate the mechanism by which TRIM11 influences regulatory T (Treg) cell stability.
Main Methods:
- Investigated TRIM11's role in CD4+ T cell differentiation and experimental autoimmune encephalomyelitis (EAE) models.
- Utilized co-immunoprecipitation and Western blotting to study TRIM11-AIM2 interactions and AIM2 degradation.
- Assessed the impact of AIM2 on signaling pathways (AKT, FOXO1, MYC) and glycolysis in Treg cells.
Main Results:
- TRIM11 was identified as a negative regulator of Treg cell differentiation in CD4+ T cells.
- TRIM11 promotes autoimmune disease development through an absent in melanoma 2 (AIM2)-dependent pathway.
- TRIM11 induces ubiquitination and autophagic degradation of AIM2 via p62, destabilizing Treg cells.
- AIM2 normally attenuates AKT/FOXO1 phosphorylation, MYC signaling, and glycolysis, promoting Treg stability.
Conclusions:
- TRIM11 negatively regulates Treg cell differentiation and stability by targeting AIM2 for degradation.
- TRIM11 plays a crucial role in promoting autoimmune disease pathogenesis.
- TRIM11 represents a potential therapeutic target for treating autoimmune diseases and cancers driven by immune dysregulation.
More Related Videos
08:20In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol
Published on: December 30, 2016
10:10Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
Published on: November 8, 2016
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Abnormal Proliferation